1
2
3
4
5
6
Vedder, Hans
Veröffentlicht in: Vedder , H 2015 , ' No Patient or Illness to be Treated? The Hazards of Investigations Carried Out nder Article 102 TFEU for Price-Related Conduct (The Netherlands, Case 7069, AstraZeneca) ' , Journal of European Competition Law & Practice , vol. 6 , no. 9 , pp. 664-668 . https://doi.org/10.1093/jeclap/lpv057;
2015
Veröffentlicht in: Vedder , H 2015 , ' No Patient or Illness to be Treated? The Hazards of Investigations Carried Out nder Article 102 TFEU for Price-Related Conduct (The Netherlands, Case 7069, AstraZeneca) ' , Journal of European Competition Law & Practice , vol. 6 , no. 9 , pp. 664-668 . https://doi.org/10.1093/jeclap/lpv057;
2015
7
8
Westra, Daan, Angeli, Federica, Carree, Martin, Ruwaard, Dirk
Veröffentlicht in: Westra , D , Angeli , F , Carree , M & Ruwaard , D 2017 , ' Understanding competition between healthcare providers: Introducing an intermediary inter-organizational perspective ' , Health Policy , vol. 121 , no. 2 , pp. 149-157 . https://doi.org/10.1016/j.healthpol.2016.11.018;
2017
Veröffentlicht in: Westra , D , Angeli , F , Carree , M & Ruwaard , D 2017 , ' Understanding competition between healthcare providers: Introducing an intermediary inter-organizational perspective ' , Health Policy , vol. 121 , no. 2 , pp. 149-157 . https://doi.org/10.1016/j.healthpol.2016.11.018;
2017
9
10